Drug compliance in diabetics.
作者信息
Eshelman F N
出版信息
Br Med J. 1978 Mar 4;1(6112):581. doi: 10.1136/bmj.1.6112.581-c.
Abstract
摘要
相似文献
1
Drug compliance in diabetics.糖尿病患者的药物依从性。
Br Med J. 1978 Mar 4;1(6112):581. doi: 10.1136/bmj.1.6112.581-c.
2
3
Blood sugar lowering effects of chlorpropamide and tolbutamide. A double blind cooperative study.氯磺丙脲和甲苯磺丁脲的降血糖作用。一项双盲合作研究。
Diabetes. 1965 Oct;14(10):650-7. doi: 10.2337/diab.14.10.650.
4
Diabetes mellitus treated with chlorpropamide and tolbutamide. A four-year clinical study.用氯磺丙脲和甲苯磺丁脲治疗糖尿病。一项为期四年的临床研究。
Diabetes. 1966 Apr;15(4):269-75. doi: 10.2337/diab.15.4.269.
5
[Diabetes mellitus therapy by sulfonylurea drugs].
Dapim Refuiim. 1969 Jan;28(1):59-64.
6
A clinical pharmacologic comparison of glyhexamide, tolbutamide and chlorpropamide in the treatment of stable diabetes.格列赫酰胺、甲苯磺丁脲和氯磺丙脲治疗稳定型糖尿病的临床药理学比较
Am J Med Sci. 1967 Mar;253(3):312-20. doi: 10.1097/00000441-196703000-00008.
7
[Dynamics of blood serum lipid and lipoprotein indices in diabetes mellitus, treated with chlorpropamide and butamide].[氯磺丙脲和丁磺酰胺治疗的糖尿病患者血清脂质和脂蛋白指标的动态变化]
Probl Endokrinol (Mosk). 1968 May-Jun;14(3):9-13.
8
Glucose tolerance in diabetes mellitus during treatment with the sulfonylurea hypoglycemic agents.磺酰脲类降糖药治疗期间糖尿病患者的糖耐量
Isr J Med Sci. 1966 Nov-Dec;2(6):733-7.
9
Status of problem of usage of tolbutamide. Preliminary statements.甲苯磺丁脲的使用问题现状。初步声明。
Diabetes. 1970 Jun;19(6):467-8.
10
[Comparative assessment of the effectiveness of certain sugar-reducing sulfanilamide preparations].
Probl Endokrinol (Mosk). 1967 May-Jun;13(3):51-4.
引用本文的文献
1
Serum glibenclamide in diabetic patients, and influence of food on the kinetics and effects of glibenclamide.糖尿病患者的血清格列本脲以及食物对格列本脲动力学和效应的影响。
Diabetologia. 1980 Jan;18(1):17-22. doi: 10.1007/BF01228296.
Zotero 插件